Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections
about
Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.Influenza A induced cellular signal transduction pathways.Pretreatment of epithelial cells with live Streptococcus pneumoniae has no detectable effect on influenza A virus replication in vitroGenesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesEnhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract.Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.Temporal association in hospitalizations for tuberculosis, invasive pneumococcal disease and influenza virus illness in South African childrenInfluenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in miceCD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans.Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive DiseaseVaccine strategies to enhance immune responses in the aged.Vaccine efficacy and T helper cell differentiation change with aging.Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides.Disordered oropharyngeal microbial communities in H7N9 patients with or without secondary bacterial lung infection.The impact of aging on CD4+ T cell responses to influenza infection.
P2860
Q30204865-EF1BAD0A-7D5B-42A4-B975-9731075F5F40Q30353167-2A4264F0-99C9-431D-A20E-1AA5B86C1A8EQ30359779-FCBDCF90-D2B7-4623-A3EF-E650C99919ECQ30361887-F7842CD8-3DE6-40FB-9015-2F641D00EAD9Q34057711-00B56652-3B47-45FB-BF1C-B06059587BFEQ34930189-2990966E-81EB-45E7-8096-CA1001C32C8DQ35115579-05D107C5-604C-4C3F-928C-F79CEDFDF92BQ35117599-490DC1CA-4D34-4E47-B2C6-C721200AD29CQ35859321-913D1B12-D213-4A1E-A793-B6999D6578EBQ36920299-2483740F-1382-4657-ACAD-8FB57D139463Q37168719-EC690A1F-B86A-4CF0-A775-C950AC619845Q37179398-C57A66A7-8DBB-4BEB-9AE9-D92979EFBBDAQ37376099-614F1812-FB62-40F7-9875-114A1A62404DQ37402775-B1BFF63E-A99A-4E28-A02A-216D4C265130Q47563285-F06173FE-C68C-4B75-913C-CAAE908A2027Q52608224-77BA311A-55DF-4CC7-A2BE-703CDE0BFA2E
P2860
Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Immunity to the conserved infl ...... secondary bacterial infections
@ast
Immunity to the conserved infl ...... secondary bacterial infections
@en
type
label
Immunity to the conserved infl ...... secondary bacterial infections
@ast
Immunity to the conserved infl ...... secondary bacterial infections
@en
prefLabel
Immunity to the conserved infl ...... secondary bacterial infections
@ast
Immunity to the conserved infl ...... secondary bacterial infections
@en
P2093
P2860
P356
P1476
Immunity to the conserved infl ...... secondary bacterial infections
@en
P2093
Ashlee H Petell
David L Woodland
Debra K Duso
Frank M Szaba
Jacob E Kohlmeier
Jr-Shiuan Lin
Julie S Lefebvre
Laura Haynes
Lawrence L Johnson
P2860
P304
P356
10.4049/JIMMUNOL.1201916
P407
P577
2012-10-01T00:00:00Z